Corteva, Inc.

Listed Company

CTVACIK 0001755672NYSELarge AcceleratedAgricultural Production-CropsDelawareFY ends Dec 31

Period

FY 2025

Revenue

$17.40B

Net Income

$1.09B

Total Assets

$42.84B

Equity

$24.14B

Shares Out

672.52M

Op. Cash Flow

$3.41B

Business

Corteva, Inc. is a global provider of seed and crop protection solutions serving the agriculture industry and advancing science-based innovations to improve farm productivity and sustainability. It offers commercial seed combining advanced germplasm and trait technologies, crop protection products including herbicides, insecticides, fungicides, nitrogen management products and biologicals, digital agronomy tools, and licensing of traits and germplasm. Operations are managed through two reportable segments: Seed and Crop Protection. Corteva markets and distributes products in approximately 110 countries through a Pioneer agency model, regional and retail brands, and licensing and distribution partners.

Summary from filing dated 2025-02-14

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Net Sales	17,401	16,908	17,226	17,455	15,655
Cost of Goods Sold	9,172	9,529	9,920	10,436	9,220
Research and Development Expense	1,474	1,402	1,337	1,216	1,187
Selling, General and Administrative Expense	3,492	3,196	3,176	3,173	3,209
Amortization of Intangibles	644	685	683	702	722
Restructuring and asset related charges - net	146	288	336	363	—
Business Separation Costs	35	0	0	—	—
Other income (expense) - net	−570	−300	−448	−60	1,348
Interest Expense	180	233	233	79	30
Income (loss) from continuing operations before income taxes	1,688	1,275	1,093	1,426	2,346
Provision for (benefit from) income taxes on continuing operations	484	412	152	210	524
Income (loss) from continuing operations after income taxes	1,204	863	941	1,216	1,822
Income (loss) from discontinued operations after income taxes	−99	56	−194	−58	−53
Net income (loss)	1,105	919	747	1,158	1,769
Net income (loss) attributable to noncontrolling interests	11	12	12	11	10
Net Income (Loss) attributable to Company	1,094	907	735	1,147	1,759
Basic earnings (loss) per share of common stock from continuing operations	1.75	1.23	1.31	1.67	2.46
Basic earnings (loss) per share of common stock from discontinued operations	−0.15	0.08	−0.27	−0.08	−0.07
Basic earnings (loss) per share of common stock	1.6	1.31	1.04	1.59	2.39
Diluted earnings (loss) per share of common stock from continuing operations	1.75	1.22	1.3	1.66	2.44
Diluted earnings (loss) per share of common stock from discontinued operations	−0.15	0.08	−0.27	−0.08	−0.07
Diluted earnings (loss) per share of common stock	1.6	1.3	1.03	1.58	2.37

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash and Cash Equivalents	4,521	3,106	2,644	3,191	4,459
Marketable Securities	9	63	98	124	86
Accounts and notes receivable - net	6,371	5,676	5,488	5,701	4,811
Inventories	5,667	5,432	6,899	6,811	5,180
Other current assets	767	820	1,131	968	1,010
Total current assets	17,335	15,097	16,260	16,795	15,546
Investments in nonconsolidated affiliates	160	134	115	102	76
Property, Plant and Equipment	9,551	9,074	8,956	8,551	8,364
Less: Accumulated Depreciation	5,331	4,975	4,669	4,297	4,035
Net Property, Plant and Equipment	4,220	4,099	4,287	4,254	4,329
Goodwill	10,465	10,408	10,605	9,962	10,107
Other intangible assets	8,301	8,876	9,626	9,339	10,044
Deferred Income Taxes	320	401	584	479	438
Other Assets	2,044	1,810	1,519	1,687	1,804
Total Assets	42,845	40,825	42,996	42,618	42,344
Short-term borrowings and finance lease obligations	894	750	198	24	17
Accounts Payable	4,398	4,039	4,280	4,895	4,126
Income Taxes Payable	155	207	174	183	146
Deferred Revenue	3,579	3,287	3,406	3,388	3,201
Accrued and other current liabilities	3,099	2,103	2,351	2,254	2,068
Total current liabilities	12,125	10,386	10,409	10,744	9,558
Long-term Debt	1,686	1,953	2,291	1,283	1,100
Deferred Income Tax Liabilities	251	478	899	1,119	1,220
Pension and other post employment benefits - noncurrent	2,434	2,271	2,467	2,255	3,124
Other noncurrent obligations	1,963	1,707	1,651	1,676	1,719
Total Noncurrent Liabilities	6,334	6,409	7,308	6,333	7,163
Common Stock, Shares, Issued	672	686	701	713	—
Common stock	7	7	7	7	7
Additional Paid in Capital	27,001	27,196	27,748	27,851	27,751
Retained earnings (accumulated deficit)	−67	55	−41	250	524
Accumulated other comprehensive income (loss)	−2,797	−3,469	−2,677	−2,806	−2,898
Total stockholders' equity attributable to the company	24,144	23,789	25,037	25,302	25,384
Noncontrolling Interests	242	241	242	239	239
Total Equity	24,386	24,030	25,279	25,541	25,623
Total Liabilities and Equity	42,845	40,825	42,996	42,618	42,344

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Depreciation and amortization	1,203	1,227	1,211	1,223	1,243
Provision for (benefit from) deferred income tax	−41	−365	−438	−288	—
Net periodic pension and OPEB (benefit) cost, net	36	160	138	−142	−1,292
Pension and OPEB contributions	−136	−151	−149	−182	247
Net (gain) loss on sales of property, businesses, consolidated companies and investments	−41	−17	−22	−18	—
Restructuring and Asset Related Charges - net	146	288	336	363	—
Other net loss	545	383	578	305	154
Accounts and Notes Receivable	−261	−705	358	−993	−113
Inventories	−35	1,110	57	−1,715	−422
Accounts Payable	231	−115	−663	807	526
Deferred Revenue	270	−86	−11	194	574
Other Assets and Liabilities	336	−296	−527	142	57
Cash Provided by (Used for) Operating Activities - Continuing Operations	3,457	2,296	1,809	912	2,769
Cash Provided by (Used for) Operating Activities - Discontinued Operations	−51	−151	−40	−40	−42
Cash provided by (used for) operating activities	3,406	2,145	1,769	872	2,727
Capital expenditures	−591	−597	−595	−605	−573
Proceeds from Sales of property, businesses, and consolidated companies - net of cash divested	54	5	57	73	—
Acquisitions of businesses - Net of Cash Acquired	0	0	−1,456	0	0
Investments in and loans to nonconsolidated affiliates	−20	−7	−32	−12	−4
Purchases of investments	0	−144	−148	−344	−204
Proceeds from Sale and Maturities of Investments	135	130	147	295	345
Payments for (Proceeds from) Hedge, Investing Activities	−83	63	42	—	—
Other investing activities - net	−38	−39	−2	−3	−1
Cash provided by (used for) investing activities	−543	−589	−1,987	−632	−362
Net Change in borrowings (less than 90 days)	0	53	−6	−13	13
Proceeds from Debt	1,730	3,072	3,429	1,358	419
Payments on Debt	−1,871	−2,885	−2,309	−1,140	−421
Repurchase of Common Stock	−1,071	−1,009	−756	−1,000	−950
Proceeds from Exercise of Stock Options	88	60	31	88	100
Dividends Paid to stockholders	−475	−458	−439	−418	−397
Other financing activities, net	−45	−32	−49	−55	−30
Cash provided by (used for) financing activities	−1,644	−1,199	−99	−1,180	−1,266
Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents	84	−93	−143	−278	−136
Increase (decrease) on cash, cash equivalents and restricted cash	1,303	264	−460	−1,218	963
Interest, net of amounts capitalized	191	244	234	75	30
Income Taxes	750	707	535	467	341

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro